Pricing Log in Create free account

Nautilus Biotechnology, Inc. (NAUT) vs Rocket Pharmaceuticals, Inc. (RCKT)

Nautilus Biotechnology, Inc. and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and Rocket Pharmaceuticals, Inc. are of similar size ($273.9M and $267.3M). Across the 10 metrics below, Rocket Pharmaceuticals, Inc. leads on 7 and Nautilus Biotechnology, Inc. on 3.

Valuation

Metric NAUT RCKT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.43 0.73 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (20.76%) (6.69%) (32.88%)
Free cash flow yield (19.43%) (63.78%) (23.13%)

Profitability

Metric NAUT RCKT Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.01%) (4.77%) (51.96%)
Return on assets (33.49%) (4.09%) (46.06%)
Return on invested capital (133.48%) (114.71%) 0.00%

Growth

Metric NAUT RCKT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 16.07% 26.37% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NAUT RCKT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 9.25 9.24 4.97
Net debt to EBITDA 1.67 0.77 1.01

Dividend

Metric NAUT RCKT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NAUT RCKT Biotechnology median
Market cap 273.85m 267.30m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack